{
    "organizations": [],
    "uuid": "4fc8035626091c7c1b65a1a7e1f56e3886cb6314",
    "author": "Reuters Editorial",
    "url": "https://www.reuters.com/article/brief-cadila-healthcares-zydus-gets-fina/brief-cadila-healthcares-zydus-gets-final-nod-from-u-s-fda-for-sedative-injection-idUSFWN1QI0JW",
    "ord_in_thread": 0,
    "title": "BRIEF-Cadila Healthcare's ‍Zydus Gets Final Nod From U.S. FDA For Sedative Injection​",
    "locations": [],
    "highlightText": "",
    "language": "english",
    "persons": [],
    "text": "Feb 28 (Reuters) - Cadila Healthcare Ltd:\n* UNIT ‍ZYDUS GETS FINAL NOD FROM U.S. FDA FOR DEXMEDETOMIDINE HYDROCHLORIDE INJECTION\n* INJECTION TO BE MANUFACTURED AT CO'S FORMULATIONS MANUFACTURING FACILITY AT MORAIYA, AHMEDABAD‍​​ Source text - bit.ly/2GMplqQ Further company coverage:\n ",
    "published": "2018-02-28T16:30:00.000+02:00",
    "crawled": "2018-03-01T21:12:21.040+02:00",
    "highlightTitle": "",
    "preprocessed_text": [
        "feb",
        "reuters",
        "cadila",
        "healthcare",
        "ltd",
        "unit",
        "get",
        "final",
        "nod",
        "fda",
        "dexmedetomidine",
        "hydrochloride",
        "injection",
        "injection",
        "manufactured",
        "co",
        "formulation",
        "manufacturing",
        "facility",
        "moraiya",
        "source",
        "text",
        "company",
        "coverage"
    ]
}